Modifiers factors of clinical severity in sickle cell anemia;Fatores moduladores da gravidade da evolução clínica da anemia falciforme

Revista Brasileira de Hematologia e Hemoterapia

Volumn 29, Issue 3, 2007, Pages 215-217

  Figueiredo, Maria Stella ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clinical severity; Epistatic genes; Modifying factors; Sickle cell anemia

Indexed keywords

EID: 38049171190     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Steinberg MH, Adewoye AH. Modifiers genes and sickle cell anemia. Curr Opin Hematol. 2006;13:131-6.
2. a edição. Oxford University Press; 1992. p. 631.
3. Fabry ME, Kaul DK. Sickle cell vaso-occlusion. Hematol/Oncol Clin N Am. 1991;5:375-98.
4. Kaul DK, Nagel RL. Sickle cell vasoocclusion: many issues and some answers. Experientia. 1993;49:5-15.
5. Nagel RL. Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia. Sem Hematol. 1991;28:180-201.
6. Madigan C, Malik P. Pathopysiology and therapy for haemoglobinopathies. Part I: sickle cell disease. Expert Ver. 2006;8:1-23.
7. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129:465-81.
8. Schnog JB, Duits AJ, Muskiet FAJ, Ten Cate H, Rojer RA, Brandjes DPM. Sickle cell disease: a general overview. Neth J Med. 2004;62:364-74.
9. Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol Sci. 2006;27:204-10.
10. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343-60.
11. Nagel RL. Sickle cell anemia is a multigene disease: sickle painful crises, a case in point. Am J Hematol. 1993;42:96-101.
12. Adekile AD, Huisman THJ. HbF in sickle cell anemia. Experientia. 1993;49:16-27.
13. s-Gene-cluster haplotypes in sickle cell anemia: clinical implications. Am J Ped Hematol/Oncol. 1990;12:367-74.
14. Garner CP, Tau T, Best S et al. Evidence of genetic interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin. Am J Hum Genet. 2002;70:793-9.
15. Chang YC, Smith KD, Moore RD et al. An analysis of fetal hemoglobin variation in sickle cell disease: the reliable contribuctions of the X-linked factor, β-globin haplotypes, α-globin gene number, gender, and age. Blood. 1995;85:1111-7.
16. Wysynski DF, Baldwin CT, Cleves MA, et al. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell Mol Biol. 2004;50:23-33.
17. Inoue A, Kuroyanagi Y, Terui K, et al. Negative regulation of gamma-globin gene expression by ciclic AMP-dependant pathway in erythroid cells. Exp Hematol. 2004;32:244-53.
18. Costa FF, Tavella MH, Zago MA. Deletion type α-thalassemia among Brazilian patients with sickle cell anemia. Braz J Genet. 1989;12:605-11.
19. Figueiredo MS, Kerbauy J, Gonçalves MS, Arruda VR, Saad ST, Sonati MF et al. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol. 1996;53:72-6.
20. Steinberg MH, Embury SH. α-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood. 1986;68:985-90.
21. Okpala I. The intringuing contribution of white blood cells to sickle cell disease - a red cell disorder. Blood Rev. 2004;18:65-73.
22. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin. Jama. 2005;293:1653-62.
23. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21:37-47.
24. Braga JAP. Avaliação do estado nutricional e importância dos oligoelementos zinco, cobre e ferro na doença falciforme. Tese de Mestrado da Escola Paulista de Medicina, 1992, 148 pp.